January 28, 2005 -- Unable to maintain its three-day winning streak, stocks sold off today. The Centient Biotech 200 made a late-day surge, almost erasing the deficit, but still closed slightly lower, off a relatively insignificant 1.88 points (just .06%) to 3341.69. Merck lost 10% after losing patent protection on a key drug, PerkinElmer got an upgrade (and we agree), IDEXX reported earnings slightly ahead of expectations, Cambridge Antibody got further favorable rulings in a British court, La Jolla Pharma will sell shares at its currently depressed price, and Neurobiological Tech got fast-track status for its stroke medication, derived from the venom of Malayan pit vipers. We give the details...
